Cutler Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20
Closed -$9K 5676
2020
Q4
$9K Sell
20
-260
-93% -$277K ﹤0.01% 3250
2020
Q3
$66K Sell
280
-400
-59% -$291K ﹤0.01% 1597
2020
Q2
$90K Buy
+680
New +$393K 0.01% 1363
2020
Q1
Sell
-120
Closed -$8K 4058
2019
Q4
$8K Buy
+120
New +$58.7K ﹤0.01% 2740

Other funds holding CDLX

Cutler Group's CDLX Position: Q4 2021 in Review

Cutler Group sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 10 shares — an estimated $8K sold.

Cutler Group first reported a position in CDLX in Q4 2019 and held it in 7 quarters. The position peaked at $238K in Q4 2020. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • Cutler Group reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 10 Cardlytics shares in Q4 2021, an estimated $8K.
  • Cutler Group first reported a position in Cardlytics in Q4 2019 and held it in 7 quarters.
  • Cutler Group's Cardlytics position peaked at $238K in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.